Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats
- 1 February 1995
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 77 (3) , 217-224
- https://doi.org/10.1016/0049-3848(95)91609-o
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patientsInternational Journal of Clinical and Laboratory Research, 1993
- Erythropoietin induced transmembrane calcium influx in essential hypertensionLife Sciences, 1992
- Anemia of renal failure: Use of ErythropoietinMedical Clinics of North America, 1992
- Serotonin is involved in some effects of erythropoietinThrombosis Research, 1992
- Coagulation Studies and Fistula Blood Flow During Erythropoietin Therapy in Haemodialysis PatientsNephrology Dialysis Transplantation, 1991
- Vascular reactivity in chronic Goldblatt two kidney-one clip hypertensive ratsCellular and Molecular Life Sciences, 1990
- Hematologic aspects of renal insufficiencyBlood Reviews, 1989